• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIABETES CARE, INC. ACCU-CHEK ® FLEXLINK INFUSION SET; SUBCUTANEOUS INFUSION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIABETES CARE, INC. ACCU-CHEK ® FLEXLINK INFUSION SET; SUBCUTANEOUS INFUSION SET Back to Search Results
Lot Number 5329885
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hyperglycemia (1905); Unspecified Infection (1930); Injection Site Reaction (4562)
Event Date 10/08/2021
Event Type  Injury  
Manufacturer Narrative
The event occurred outside of the united states.While this product is not sold in the united states, it is like or similar to a product marketed in the united states.
 
Event Description
It was reported that the patient experienced an infection at the insertion site while wearing the infusion set.The caller reported that on (b)(6) 2021 she inserted the accu-chek flexlink infusion set into her thigh.A few hours later she felt pain at the insertion site and noticed some swelling and her blood glucose levels were elevated.She kept the cannula inserted until (b)(6) 2021, and then decided to remove it as she was experiencing a lot of pain.Once she removed the cannula she had a purple hematoma, swelling, and pain.On (b)(6) 2021 she bumped the site and pus discharged and swelling increased.The customer took medication she had at home of dexamethasone acetate 1 mg/g and neomycin sulphate bacitracin zincid 5 mg/g + 250 iu/g, but she reported that it wasn¿t getting any better.On (b)(6) 2021 the customer went to the hospital.She stayed under observation at the hospital for 6 hours and was given analgesics and an unknown injection.The doctor at the hospital also prescribed her clavulin 500+125mg from 08 to 08 hours.She started the use of this ointment on (b)(6) 2021.The customer reported that the affected site is still red, but swelling has now reduced.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCU-CHEK ® FLEXLINK INFUSION SET
Type of Device
SUBCUTANEOUS INFUSION SET
Manufacturer (Section D)
ROCHE DIABETES CARE, INC.
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
UNOMEDICAL DEVICES S.A. DE C.V
avenida fomento industrial lot
parque industrial del norte
reynosa C.P. 8873
MX   C.P. 88736
Manufacturer Contact
john krug
9115 hague road
na
indianapolis, IN 46250-0457
3175212484
MDR Report Key12699366
MDR Text Key278537450
Report Number3011393376-2021-03343
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeBR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/26/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/01/2022
Device Lot Number5329885
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/10/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Patient Sequence Number1
Treatment
UNKNOWN CARDIOVASCULAR MEDICATION; UNKNOWN NEUROPATHY MEDICATION
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age21 YR
Patient SexFemale
-
-